The Global Artificial Pancreas Market is expected to reach $ 360 million by the end of 2023, this market is projected to growing at a CAGR of ~ 15.2 % during 2017-2023.
The present market is dominated by the threshold suspended device segment and Medtronic’s device series MiniMed leads the market for threshold suspended device segment. The Artificial Pancreas Market is chiefly driven by rise in diabetes which is again driven by rise in risk factors such as sedentary lifestyles, unhealthy foods such as fast foods with poor fibre content, high sugar content, lack of exercise etc. Other drivers of anal fissures include the rising screening for diabetes.
Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/3854 .
The threshold suspend device system act by temporarily suspending infusion of insulin, when the body glucose level falls to a set low threshold. These systems require frequent patient inputs to avoid a hypoglycaemic event. However, the control-to-range (CTR) system, and control-to-target (CTT) system are expected to gain momentum due to the greater automation, low manual input requirement and their ability to more precisely mimic the working of the natural pancreas system.Remote monitoring and connected artificial pancreas systems are expected to represent the future of the technology.
Several closed loop systems including Inreda’s artificial pancreas, Bionic pancreas etc. are in advanced stages of testing for remote monitoring. Another advancement has been the development of the bi-hormonal system which delivers insulin along with another hormone such as glucagon to increase blood glucose levels and more closely mimics the glucose-regulating function of a healthy pancreas than the insulin-only system.
Global Artificial pancreas Market Players:
Key players profiled in the report are Medtronic, Johnson & Johnson, Beta Bionics, Bigfoot Biomedical, Admetsys (pipeline product analysis), Animas Corporation, Defymed, dexcom, Insulet, Johnson & Johnson, medtech, medtronic, Semma Therapeutics, Tandem Diabetes Care, TypeZero Technologies, and others.
Check Attractive Discount @ https://www.marketresearchfuture.com/check-discount/3854 .
Regional analysis
US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global artificial pancreas. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most potential which is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.
Brief TOC
1. Introduction
2. Research Methodology
3. Market Dynamics
4. Market Factor Analysis
5. Global Artificial Pancreas Market, By Control Type
6. Global Artificial Pancreas Market, By Treatment Type
7. Global Artificial Pancreas Market, By End Users
8. Global Artificial Pancreas Market, By Region
9. Competitive Landscape
10. Company Profile
11. Conclusion
12. Appendix
Ask to Expert @ https://www.marketresearchfuture.com/enquiry/3854 .
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/artificial-pancreas-market-3854